Policy Watch: 20 Regulatory Updates — March 20, 2026
This update covers drug enforcement controlled substances regulatory policy changes relevant to cannabis clinicians. It highlights new scheduling of synthetic cannabinoids and benzodiazepine analogs. Clinicians should stay informed on these regulatory…
Policy Watch: 10 Regulatory Updates — March 18, 2026
This Policy Watch covers the DEA marijuana rescheduling 2026 proposal and other key regulatory updates affecting cannabis clinicians. The rescheduling could facilitate research and patient access by acknowledging medical utility. These regulatory changes…
Policy Watch: 27 Regulatory Updates — March 16, 2026
This Policy Watch covers the DEA temporary schedule I placement and 27 regulatory updates as of March 16, 2026. These updates include synthetic opioids and benzodiazepine analogs relevant to cannabis clinicians. Stay informed on controlled substances…